Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Reducing Alcohol-Involved Suicidal Ideation and Behavior

16 de novembro de 2026 atualizado por: Amanda Gilmore, Georgia State University

The goal of this clinical trial is to learn whether a brief skills training can help people cope better with distress and reduce suicidal thoughts and behaviors that happen along with alcohol use. The study looks at this both in a lab and in everyday life. It is for adults ages 21 to 54 who currently have thoughts of suicide and who engage in heavy episodic drinking (drinking a large amount of alcohol on a single occasion; specifically, 4 drinks in 2 hours for females and 5 drinks in 2 hours for males).

The main questions it aims to answer are:

  • Can two coping skills from Dialectical Behavior Therapy (paced breathing and expanding awareness) reduce distress, suicidal thoughts, and urges to self-harm while a person has been drinking alcohol?
  • Can text messages sent during the two weeks after the lab visit help people who drink alcohol have fewer suicidal thoughts and behaviors, compared with getting no text messages?

Visão geral do estudo

Descrição detalhada

Suicide is a serious public health problem in the United States, accounting for more than 47,000 deaths in 2019. Rates of suicide have increased 33% in the past 20 years and have consistently ranked within the 10 leading causes of death in the United States. Decades of rigorous research has consistently found that alcohol is associated with suicidal ideation and behavior (SIB). Despite interventions shown to reduce SIB while sober, high rates of intoxicated SIB may persist because current skills-based interventions: (1) are time and resource intensive, (2) may not be salient to individuals while drinking limiting their ability to engage in them to decrease distress and (3) may be too complicated to use effectively when intoxicated even if they are salient.

Distress tolerance skills from Dialectical Behavior Therapy (DBT) have been shown to be acceptable and effective for suicidal individuals who engage in heavy episodic drinking (HED). However, it is unknown if these skills are effective while intoxicated when risk for SIB is known. Moreover, just-in-time (JIT) interventions may be critical for reducing alcohol-involved SIB because they are designed to provide support when needed and can be delivered close in time to drinking episodes when in-the-moment distress and SIB risk.

The investigators carefully selected two DBT skills simple enough to be implemented while intoxicated to prevent intoxicated SIB. These two skills use counts of 5 and 7 to focus attention on internal and environmental stimuli (expanding awareness skill) and counting breaths (paced breathing skill), hereafter referred to as "5-7 skills". Expanded awareness is a mindfulness skill that can mitigate the myopic narrowing of attentional focus on suicidal thoughts during intoxication. Paced breathing is a distress tolerance skill that can reduce in-the-moment distress by activating the parasympathetic nervous system within minutes. The 5-7 skills are ideal for reducing intoxicated SIB due to their simplicity thus increasing their usability and feasibility while intoxicated.

This study will conduct a proximal change experiment and a micro-randomized trial (MRT) of a brief mobile-based behavioral intervention for SIB while intoxicated. Specifically, the investigators will evaluate the efficacy of 5-7 skills under conditions of acute intoxication using a laboratory-based proximal change experiment to evaluate the efficacy of skills in a controlled environment. Next, the investigators will conduct an MRT to evaluate and optimize the delivery of a JIT intervention including 5-7 skills.

Upon arrival to the laboratory, participants will undergo a brief survey to re-ensure eligibility and to assess biological eligibility. Participants will also complete a field sobriety test. Next, participants will complete the pre-session suicide risk assessment (UWRAMP) to assess for baseline suicide risk upon entering the study. Participants will complete a baseline survey and will then be randomized to the intervention or control condition.

All participants will be served alcoholic (alcohol/juice) drinks. Participants will be administered two drinks consisting of an overall dose to reach .08% breath alcohol concentration (i.e., .816 ml/lb of 100 proof alcohol for males, .752ml/lb of 100 proof alcohol for females) mixed in a 1:3 ratio with juice. The beverage will be poured into two glasses in equal quantities. Participants will be given each drink at equally-spaced times during a twenty-minute interval to control for drinking rate. BrACs will be monitored every five minutes after finishing their beverages with the Alco-Sensor IV breath analyzer. Subjective intoxication and suicidal urges will be assessed each time they are breathalyzed. Once participants reach a criterion BrAC of .05% or greater they will complete the distress tolerance tasks.

Participants will complete two tasks which assess distress tolerance including a mirror tracing task and the PASAT (Paced Auditory Serial Addition Test; see questionnaire battery for a description of each assessment). Participants will either be instructed to practice the 5-7 skills while completing the assessments of distress tolerance if they were assigned to the 5-7 condition or provided no instructions for the control condition. Suicidal and self-harm urges, distress, and alcohol cravings will be assessed during the distress tolerance assessments. Participants' BrAC will be assessed following the completion of these tasks to ensure participants were on the ascending BrAC limb during the experimental procedures. Participants will be served lunch. BrAC will continue to be assessed every 20 minutes. Suicidal/self-harm urges will continue to be assessed verbally via an experimenter while participants are on the descending BrAC limb. Participants will not be allowed to leave the laboratory until their BrAC has fallen to 0.02% on two consecutive readings (following NIAAA guidelines) and they have passed a field sobriety test, and in accordance with prior procedures used by the research team. The post-session suicide risk assessment will be completed prior to completing study procedures to ensure participant safety. Upon completion of study tasks, study personnel will arrange a safe departure for the participant (e.g., Uber/Lyft, bus/train pass, friend/family member pick up).

Following the in-lab session, participants will be asked to complete twice-daily surveys each morning and evening for 14 days to assess their affect, distress, SIB, and alcohol use. Following each report or at the end of the response window if no report is made, the delivery of JIT text messages will be micro-randomized, once in the morning following the morning report, and once in the evening following the evening report. Participants will be randomized with equal probability to receive (a) a message focusing on a 5-7 skill or (b) no message. Participants will receive on average 1 message per day (either in the morning or the evening), with equal chance of receiving each of the 5-7 skills (expanded awareness or paced breathing). Messages will be sent automatically using Qualtrics, which allows users to set-up SMS message triggers following a survey completion or at a predetermined time if no survey was completed.

Tipo de estudo

Intervencional

Inscrição (Estimado)

240

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Kennicia Fortson, PhD
  • Número de telefone: 404-413-1416
  • E-mail: kfortson4@gsu.edu

Estude backup de contato

Locais de estudo

    • Georgia
      • Atlanta, Georgia, Estados Unidos, 30303
        • Georgia State University
        • Investigador principal:
          • Amanda K Gilmore, PhD
        • Contato:
        • Contato:
        • Investigador principal:
          • Cynthia Stappenbeck, PhD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

21 anos a 54 anos (Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Ages 21 to 54
  • Suicidal ideation at least once in the past month;
  • Heavy episodic drinking at least once in the past month

Exclusion Criteria:

  • Any medical contraindications to alcohol use
  • Past-month opioid use
  • Pregnant
  • Have had a psychotic episode in the past month
  • Are in or seeking treatment for an alcohol use disorder
  • Have not consumed the amount of alcohol in the past month that would be administered during the proximal change experiment

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: 5-7 Skills Training

Skills training followed by randomized text messages.

The skills training session lasts for 30 minutes, where a researcher teaches two existing evidence-based skills from Dialectical Behavior Therapy to the participant and provides time to practice with feedback and reflection. Expanded Awareness skill: Participants observe five internal experiences (e.g., physical sensations, thoughts, emotions), then participants observe seven things in their environment (e.g., sounds, objects, colors). This intentional expansion of attention is intended to counter cognitive effects of intoxication that may restrict attention to distress/suicidal urges for individuals with SIB. Paced breathing skill: Participants are instructed to slow down their breathing so that their exhalation is longer than their inhalation (e.g., 5-second inhalation, 7-second exhalation). This intentional slowing of one's breathing affects the parasympathetic nervous system and helps to slow down other physical sensations associated with physiological arousal (e.g., heart rate).

Following their lab visit, participants will complete twice-daily surveys each morning and evening for 14 days to assess their affect, distress, SIB, and alcohol use. Following each report or at the end of the response window if no report is made, the delivery of JIT text messages will be micro-randomized, once in the morning following the morning report, and once in the evening following the evening report. Participants will be randomized with equal probability to receive (a) a message focusing on a 5-7 skill or (b) no message. Participants will receive on average 1 message per day (either in the morning or the evening), with equal chance of receiving each of the 5-7 skills (expanded awareness or paced breathing).

Outro: Assessment-Only Control

Assessment-only in the lab, with no skills training, followed by the same randomized text messages. This group is first introduced to the skills through the messages.

Following their lab visit, participants will complete twice-daily surveys each morning and evening for 14 days to assess their affect, distress, SIB, and alcohol use. Following each report or at the end of the response window if no report is made, the delivery of JIT text messages will be micro-randomized, once in the morning following the morning report, and once in the evening following the evening report. Participants will be randomized with equal probability to receive (a) a message focusing on a 5-7 skill or (b) no message. Participants will receive on average 1 message per day (either in the morning or the evening), with equal chance of receiving each of the 5-7 skills (expanded awareness or paced breathing).

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Suicidal Urges During the Laboratory Session
Prazo: Day 1 (baseline through end of laboratory session)

Suicidal ideation assessments will include additional questions specifically tailored to this research project to assess suicidal ideation and behavior while intoxicated. Participants will be asked, "On a scale of 1 (no urges at all) to 10 (the strongest, most intense urges possible), rate the intensity of your suicidal urges." Ratings are collected at baseline, every 5 minutes during alcohol administration before the distress tolerance tasks, and every 20 minutes after the tasks are completed.

Day 1 (baseline through end of laboratory session)
Self-Harm Urges During the Laboratory Session
Prazo: Day 1 (baseline through end of laboratory session)

Suicidal ideation assessments will include additional questions specifically tailored to this research project to assess suicidal ideation and behavior while intoxicated. Participants will be asked, "On a scale of 1 (no urges at all) to 10 (the strongest, most intense urges possible), rate the intensity of your urge to harm yourself." Ratings are collected at baseline, every 5 minutes during alcohol administration before the distress tolerance tasks, and every 20 minutes after the tasks are completed.

Day 1 (baseline through end of laboratory session)
Suicidal Thoughts in Daily Surveys Over 14 Days
Prazo: Up to 14 days after the laboratory session

Suicidal thoughts assessed using items adapted from Dialectical Behavior Therapy (DBT) diary cards, including questions about experiences while intoxicated, completed in an online survey each morning and evening for 14 days following the laboratory session. Participants will be asked to consider their most intense thought of the day and answer the following questions on a scale of 1 (no thoughts at all) to 10 (the strongest, most intense thoughts): What was the intensity of your suicidal thoughts [today/yesterday]?

Up to 14 days after the laboratory session
Suicidal Urges in Daily Surveys Over 14 Days
Prazo: Up to 14 days after the laboratory session

Suicidal urges will be assessed using an item adapted from Dialectical Behavior Therapy (DBT) diary cards, including questions about experiences while intoxicated, completed in an online survey each morning and evening for 14 days following the laboratory session. Participants will be asked to consider their most intense urge of the day and answer the following question on a scale of 1 (no urges) to 10 (the strongest, most intense urges): What was the intensity of your suicidal urges [today/yesterday]?

Up to 14 days after the laboratory session
Distress Tolerance During the Laboratory Session as Assessed by a Modified DTS
Prazo: Day 1 (during distress tolerance tasks)

Distress tolerance is assessed using a modified version of the Distress Tolerance Scale, adapted to assess distress tolerance while intoxicated. Each item is rated from 0 (strongly disagree) to 5 (strongly agree). Mean scores range from 0 to 5, with higher scores indicating lower distress tolerance (worse outcome).

Day 1 (during distress tolerance tasks)
Distress Tolerance During the Laboratory Session as Assessed by MTPT-C
Prazo: Day 1 (during distress tolerance tasks)

The Mirror Tracing Persistence Task Computerized Version (MTPT-C) will be used to assess distress tolerance in the proximal change experiment. For the task, the score is the time in seconds spent on the final, most difficult level (minimum 0; maximum is the task time limit). Shorter times indicate lower distress tolerance (worse outcome); longer times indicate higher distress tolerance (better outcome).

Day 1 (during distress tolerance tasks)
Distress Tolerance During the Laboratory Session as Assessed by PASAT-C
Prazo: Day 1 (during distress tolerance tasks)

The Paced Auditory Serial Addition Test-Computerized version (PASAT-C) will be used to assess distress tolerance in the proximal change experiment. For the task, the score is the time in seconds spent on the final, most difficult level (minimum 0; maximum 600). Shorter times indicate lower distress tolerance (worse outcome); longer times indicate higher distress tolerance (better outcome).

Day 1 (during distress tolerance tasks)
Distress Tolerance During the Laboratory Session via Self-Report
Prazo: Day 1 (during distress tolerance tasks)

Participants will answer a self-report measure of distress (e.g., "On a scale of 1 (no distress at all) to 100 (the most distress possible), rate your level of distress).

Day 1 (during distress tolerance tasks)
Distress Tolerance in Daily Surveys Over 14 Days
Prazo: Up to 14 days after the laboratory session

Two items will be randomly selected from the 15-item Distress Tolerance Scale to be assessed during each EMA survey over 14 days. Distress tolerance is assessed in each daily survey (morning and evening) using items adapted from the Distress Tolerance Scale. Each item is rated from 1 (strongly disagree) to 5 (strongly agree). At each survey, the score is the mean rating of the items administered (range 1 to 5), with higher scores indicating lower distress tolerance (worse outcome).

Up to 14 days after the laboratory session
Suicidal Ideation and Behaviors as Assessed by C-SSRS
Prazo: From baseline to 14 days after the laboratory session

Suicidal ideation and behaviors will be assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS) at baseline and each follow-up assessment.

From baseline to 14 days after the laboratory session

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Cynthia Stappenbeck, PhD, Georgia State University
  • Investigador principal: Amanda K Gilmore, PhD, Georgia State University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de abril de 2027

Conclusão Primária (Estimado)

1 de junho de 2031

Conclusão do estudo (Estimado)

1 de junho de 2031

Datas de inscrição no estudo

Enviado pela primeira vez

20 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • H27013
  • 1R01AA033115-01 (Concessão/Contrato do NIH dos EUA)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

A Global Unique Identifier (GUID) will be generated for each participant so that data can be linked without using personal identifiers. De-identified individual participant data will be shared through the NIAAA Data Archive (NIAAADA), which is housed within the NIMH Data Archive (NDA), in accordance with the study's data sharing plan.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever